MYC and in situ carcinoma: This is reflected by that elevated c-Myc is a mediator in CIS resistance via up regulating cyclin E. c-Myc is related to cell cycle progression via preventing p21 expression, a protein that dephosphorylates and tags Rb for degradation [27].